57 related articles for article (PubMed ID: 38561479)
21. Increased Circulating Epithelial Tumor Cells (CETC/CTC) over the Course of Adjuvant Radiotherapy Is a Predictor of Less Favorable Outcome in Patients with Early-Stage Breast Cancer.
Mäurer M; Schott D; Pizon M; Drozdz S; Wendt T; Wittig A; Pachmann K
Curr Oncol; 2022 Dec; 30(1):261-273. PubMed ID: 36661670
[TBL] [Abstract][Full Text] [Related]
22. Whole Genome Sequencing of Single-Circulating Tumor Cell Ameliorates Unraveling Breast Cancer Heterogeneity.
Li Y; Jiang X; Zhong M; Yu B; Yuan H
Breast Cancer (Dove Med Press); 2022; 14():505-513. PubMed ID: 36597488
[TBL] [Abstract][Full Text] [Related]
23. Signatures of Breast Cancer Progression in the Blood: What Could Be Learned from Circulating Tumor Cell Transcriptomes.
Fina E
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428760
[TBL] [Abstract][Full Text] [Related]
24. A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix
Cohen EN; Jayachandran G; Moore RG; Cristofanilli M; Lang JE; Khoury JD; Press MF; Kim KK; Khazan N; Zhang Q; Zhang Y; Kaur P; Guzman R; Miller MC; Reuben JM; Ueno NT
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358657
[TBL] [Abstract][Full Text] [Related]
25. Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie Hospitals.
Chalumeau C; Carton M; Eeckhoutte A; Ballet S; Vincent-Salomon A; Vuagnat P; Bellesoeur A; Pierga JY; Stern MH; Bidard FC; Lerebours F
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565244
[TBL] [Abstract][Full Text] [Related]
26. Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer.
Obermayr E; Koppensteiner N; Heinzl N; Schuster E; Holzer B; Fabikan H; Weinlinger C; Illini O; Hochmair M; Zeillinger R
J Pers Med; 2021 Nov; 11(11):. PubMed ID: 34834576
[TBL] [Abstract][Full Text] [Related]
27. Partial breast irradiation versus whole breast radiotherapy for early breast cancer.
Hickey BE; Lehman M
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD007077. PubMed ID: 34459500
[TBL] [Abstract][Full Text] [Related]
28. Development and validation for prognostic nomogram of epithelial ovarian cancer recurrence based on circulating tumor cells and epithelial-mesenchymal transition.
Yang J; Ma J; Jin Y; Cheng S; Huang S; Zhang N; Wang Y
Sci Rep; 2021 Mar; 11(1):6540. PubMed ID: 33753862
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of sensitivity and specificity of CanPatrol™ technology for detection of circulating tumor cells in patients with non-small cell lung cancer.
Li J; Liao Y; Ran Y; Wang G; Wu W; Qiu Y; Liu J; Wen N; Jing T; Wang H; Zhang S
BMC Pulm Med; 2020 Oct; 20(1):274. PubMed ID: 33081780
[TBL] [Abstract][Full Text] [Related]
30. Cancer statistics, 2020.
Siegel RL; Miller KD; Jemal A
CA Cancer J Clin; 2020 Jan; 70(1):7-30. PubMed ID: 31912902
[TBL] [Abstract][Full Text] [Related]
31. Genetics of breast cancer: management strategies and risk-reducing surgery.
Balasubramanian R; Rolph R; Morgan C; Hamed H
Br J Hosp Med (Lond); 2019 Dec; 80(12):720-725. PubMed ID: 31822191
[TBL] [Abstract][Full Text] [Related]
32. Detection of Circulating Tumor Cell Molecular Subtype in Pulmonary Vein Predicting Prognosis of Stage I-III Non-small Cell Lung Cancer Patients.
Dong J; Zhu D; Tang X; Qiu X; Lu D; Li B; Lin D; Zhou Q
Front Oncol; 2019; 9():1139. PubMed ID: 31737568
[No Abstract] [Full Text] [Related]
33. ASCO 2018: highlights in HER2-positive metastatic breast cancer.
Bartsch R; Bergen E
Memo; 2018; 11(4):280-283. PubMed ID: 30595754
[TBL] [Abstract][Full Text] [Related]
34. Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer.
Papadaki MA; Stoupis G; Theodoropoulos PA; Mavroudis D; Georgoulias V; Agelaki S
Mol Cancer Ther; 2019 Feb; 18(2):437-447. PubMed ID: 30401696
[TBL] [Abstract][Full Text] [Related]
35. Antiplatelet Therapy in Breast Cancer Patients Using Hormonal Therapy: Myths, Evidence and Potentialities - Systematic Review.
Leite AM; Macedo AVS; Jorge AJL; Martins WA
Arq Bras Cardiol; 2018 Aug; 111(2):205-212. PubMed ID: 30183988
[TBL] [Abstract][Full Text] [Related]
36. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.
Wolff AC; Hammond MEH; Allison KH; Harvey BE; Mangu PB; Bartlett JMS; Bilous M; Ellis IO; Fitzgibbons P; Hanna W; Jenkins RB; Press MF; Spears PA; Vance GH; Viale G; McShane LM; Dowsett M
J Clin Oncol; 2018 Jul; 36(20):2105-2122. PubMed ID: 29846122
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer intratumour heterogeneity: current status and clinical implications.
Joseph C; Papadaki A; Althobiti M; Alsaleem M; Aleskandarany MA; Rakha EA
Histopathology; 2018 Nov; 73(5):717-731. PubMed ID: 29722058
[TBL] [Abstract][Full Text] [Related]
38. Suppression of PTEN/AKT signaling decreases the expression of TUBB3 and TOP2A with subsequent inhibition of cell growth and induction of apoptosis in human breast cancer MCF-7 cells via ATP and caspase-3 signaling pathways.
Yang Z; Liu Y; Shi C; Zhang Y; Lv R; Zhang R; Wang Q; Wang Y
Oncol Rep; 2017 Feb; 37(2):1011-1019. PubMed ID: 28075472
[TBL] [Abstract][Full Text] [Related]
39. Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration.
Bray F; Ferlay J; Laversanne M; Brewster DH; Gombe Mbalawa C; Kohler B; Piñeros M; Steliarova-Foucher E; Swaminathan R; Antoni S; Soerjomataram I; Forman D
Int J Cancer; 2015 Nov; 137(9):2060-71. PubMed ID: 26135522
[TBL] [Abstract][Full Text] [Related]
40. Allelic imbalance at the HER2/TOP2A locus in breast cancer.
Huijsmans CJ; van den Brule AJ; Rigter H; Poodt J; van der Linden JC; Savelkoul PH; Hilbink M; Hermans MH
Diagn Pathol; 2015 May; 10():56. PubMed ID: 26022247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
